Pefcalcitol

N/A

Report date: 2023/04/19 20:00:28
NME

Base Information

Drug NamePefcalcitol
Drug Alias NamePefcalcitolum五氟骨化醇培夫骨化醇M-518101M-5180 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action3',5'-cyclic phosphodiesterase inhibitors
Targets3',5'-cyclic phosphodiesterase
Therapy Area/IndicationsPlaque psoriasisPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBulgariaUnited StatesPoland +[8] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMaruho Pharmaceutical
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMaruho North America IncMaruho Europe LtdMaruho Co Ltd
Active IndicationsN/A
Inactive IndicationsPlaque psoriasisPsoriasis

Other Information

ATC CodeN/A
Related LinksKEGG